SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-24-118083
Filing Date
2024-04-26
Accepted
2024-04-26 16:15:54
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-26

Document Format Files

Seq Description Document Type Size
1 ARS d770324dars.pdf ARS 2985248
  Complete submission text file 0001193125-24-118083.txt   4113613
Mailing Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007
Business Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007 858-400-8470
Viracta Therapeutics, Inc. (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 000-51531 | Film No.: 24883982
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)